Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

Recordati gets a franchise that will add to ... of its strategy to become a true global player in the treatment of rare diseases.” The sale of the three drugs comes as Novartis is in the midst ...